Part of the Menarini Group, Lusochimica aims to create a greener, more efficient synthesis of nebivolol, a widely used cardiovascular drug. The project will immobilise two alcohol dehydrogenase enzymes on solid support and integrate them into flow chemistry, optimising conditions at the laboratory and pilot scale. By establishing a European-based, competitive production, this initiative enhances sustainability, scalability, and pharmaceutical sovereignty.
- Beneficiaries
Coordinators: Lusochimica
- Project Locations
Italy
- EU funding
€1.7 million
- Funding sources
Other STEP stories
- Highlighted
Axelera-FAST (Fueling Axelera’s Semiconductor & AI Transformation) is a project designed to scale Axelera AI up and mass-produce Europe’s first fully sovereign AI acceleration platform.
- Highlighted
The Small UAS project encompasses an advanced AI-driven group system of 10 unmanned aerial systems (UAS), specifically designed for operations in air, land, and maritime environments.
OpenEuroLLM will develop a family of Large Language Model (LLMs) covering all EU official languages, ensuring transparency, compliance with the AI Act, and uptake among European businesses, startups, and innovators